Estrosmart
Natural health product licensed in Canada
- Licence holder
- Jamieson Laboratories Ltd./ Nutricorp International
- NPN or DIN-HM
- 80029438
- Status
- Active licence
- Licence date
- 7 February 2012
- Revision date
- 8 September 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Brassica oleracea L.: L'étiquetage doit comporter un avertissement recommandant aux personnes ayant une hypothyroïdie ou un traitement de la thyroïde de consulter leur médecin.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Camellia sinensis Source : Feuille Potency : 70 % Catechins | Not specified | Not calculated |
| Camellia sinensis Source : Feuille Potency : 90 % Polyphenols | Not specified | Not calculated |
| Camellia sinensis Source : Feuille Potency : 50 % Epigallocatechin 3-gallate | Not specified | Not calculated |
| 3,3'-Methylenebis-1H-indole Source : 3,3'-diindolylméthane | 25 mg | Not calculated |
| Brassica oleracea var. italica Source : Germe(s) Extraction ratio : 20:1 Dry plant equivalent : 2,000 mcg Potency : 0.4 % Sulforaphane | 100 mcg | Not calculated |
| Camellia sinensis Source : Feuille Extraction ratio : 15:1 Dry plant equivalent : 1,500 mg Potency : 2 % Caffeine | 50 mg | Not calculated |
| Sel de calcium acide d-Glucarique Source : Calcium D-saccharate | 75 mg | Not calculated |
Non-medicinal ingredients
Eau purifiée, Stéarate de magnésium, Microcrystalline cellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 2 Capsule ; maximum: 4 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
ESTROSMART is an antioxidant for the maintenance of good health. Helps support/promote healthy estrogen metabolism and supports/promotes a healthy estrogen metabolite ratio. Provides antioxidants, Provides factors for BPA detoxification. Used in Herbal Medicine to promote a healthy liver. Supports the production of desirable estrogen metabolism. Helps support glucuronidation, a liver detoxification pathway. Maintains a healthy estrogen-to-progesterone balance. Helps support estrogen metabolism by promoting a higher 2-hydroxyestrone to 16-hydroxyestrone ratio. Helps reduce the severity and duration of symptoms associated with cyclical mastalgia (recurrent breast pain).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80029438
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.